Insider Trading March 19, 2026

Zscaler Director Executes Small Share Sale Amid Mixed Analyst Views and Strong Q2 Results

Director James A. Beer sold 177 shares under a 10b5-1 plan as the stock trades near its 52-week low while analysts adjust targets

By Jordan Park ZS
Zscaler Director Executes Small Share Sale Amid Mixed Analyst Views and Strong Q2 Results
ZS

James A. Beer, a director at Zscaler, sold 177 shares on March 18, 2026 under a Rule 10b5-1 plan, generating $27,174 in proceeds. The sale leaves Beer with 4,384 shares. The transaction occurred against a backdrop of a 47% share decline over six months, a current price near the 52-week low, multiple analyst price-target revisions, and company-reported strength in fiscal 2026 second-quarter results.

Key Points

  • Director James A. Beer sold 177 shares on March 18, 2026 at $153.53 under a Rule 10b5-1 plan and now owns 4,384 shares.
  • Zscaler reported Q2 fiscal 2026 revenue growth of 26% and ARR growth of 25%, and plans a data sovereignty deployment in Canada.
  • Analysts have adjusted views: Wells Fargo initiated Overweight coverage; TD Cowen, BMO Capital, and Stifel reduced price targets for differing reasons.

James A. Beer, a member of Zscaler Inc.'s board of directors, disposed of 177 shares of the company’s common stock on March 18, 2026. The shares were sold at $153.53 apiece, producing gross proceeds of $27,174. That trade was executed pursuant to a Rule 10b5-1 trading arrangement that Beer adopted on October 3, 2025. After the sale, Beer directly holds 4,384 shares of Zscaler.

The insider sale comes as Zscaler’s equity has faced a pronounced pullback. Over the last six months the stock has fallen about 47%, and at the time of the report it was trading at $155.40 - close to its 52-week low of $140.56. Independent analysis from InvestingPro places a Fair Value on the stock at $195.17 and notes that in-depth coverage is available through InvestingPro’s Pro Research Report for ZS and more than 1,400 other U.S. equities.

Recent company disclosures also underline revenue strength. Zscaler reported second-quarter fiscal 2026 results showing a 26% year-over-year increase in revenue and a 25% rise in annual recurring revenue. The company highlighted solid performance in data security, artificial intelligence-related initiatives, and its Zero Trust Exchange offering. Management additionally announced plans to expand data sovereignty capabilities with a deployment planned in Canada to bolster its global data center footprint.

Market participants and sell-side analysts have reacted with a range of assessments. Wells Fargo initiated coverage with an Overweight rating, pointing to platform growth and labeling the current price as an attractive entry point amid concerns related to Red Canary. TD Cowen trimmed its price target to $220 from $260, citing worries about market contraction. BMO Capital reduced its target to $210 from $315 while simultaneously raising its fiscal 2026 annual recurring revenue estimate by $32 million. Stifel lowered its price target to $180 from $320 but maintained a Buy rating, noting that Zscaler’s results surpassed guidance and estimates across multiple metrics.

While the director-level sale is modest in dollar terms relative to institutional volumes, the transaction is one datapoint among several developments investors may weigh: persistent share weakness over recent months, analyst target revisions, and the company’s reported top-line and recurring revenue expansion. The combination of near-term market skepticism and the firm’s reported operational progress frames the current investor debate over valuation and momentum.


Key points

  • Director James A. Beer sold 177 Zscaler shares on March 18, 2026 for $153.53 each under a Rule 10b5-1 plan; he now holds 4,384 shares.
  • Zscaler posted 26% revenue growth and 25% ARR growth in Q2 fiscal 2026 and plans a Canada deployment to expand data sovereignty capabilities.
  • Analysts have varied in response - Wells Fargo started coverage with an Overweight rating, while TD Cowen, BMO Capital, and Stifel have lowered price targets amid differing views on market conditions and ARR outlooks.

Risks and uncertainties

  • Ongoing share-price weakness - the stock has fallen 47% over six months and trades close to its 52-week low, reflecting market sentiment in the technology and cybersecurity sectors.
  • Analyst target reductions - multiple firms have cut price targets, introducing valuation uncertainty for investors focused on enterprise software and cloud security providers.
  • Market contraction concerns - at least one firm cited market contraction as a reason to lower its target, indicating sector-wide demand risks that could affect Zscaler’s growth trajectory.

Risks

  • Continued share-price pressure - the stock has declined 47% over the past six months and is trading near its 52-week low, affecting the technology and cybersecurity sectors.
  • Analyst price-target cuts and revisions create valuation uncertainty for enterprise software and cloud security investors.
  • Concerns about market contraction and competitive dynamics (referenced in analyst commentary) could weigh on demand in cybersecurity and related IT services.

More from Insider Trading

Alignment Healthcare CHRO Disposes $425k in Shares Across Two Transactions Mar 19, 2026 CytomX SVP Sells Shares to Cover RSU Taxes as Company Advances Clinical and Financing Plans Mar 19, 2026 Silver Lake Sells $36.7M in Dell Shares as Company Reports Strong AI Server Performance Mar 19, 2026 Venture Global Accounting Chief Sells $3.2M in Stock; Options Activity Follows Mar 19, 2026 Global Partners COO Disposes of 2,223 Units in Two Trades Worth $105,751 Mar 19, 2026